Activation of the Nociceptin/Orphanin FQ system is unable to reverse CRF2 receptor mediated anorexia in the rat

Peptides

Volumn 27, Issue 12, 2006, Pages 3284-3291

  Fedeli, Amalia ^a   Policani, Federica ^a   Ubaldi, Massimo ^a   Cippitelli, Andrea ^a   Massi, Maurizio ^a   Ciccocioppo, Roberto ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

CRF receptors; Food intake; Nociceptin Orphanin FQ; NOP receptors; Urocortin II; Urocortin III

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; NOCICEPTIN; UROCORTIN; UROCORTIN III; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; ANOREXIA; DRINKING; INJECTIONS, INTRAVENTRICULAR; MALE; OPIOID PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; UROCORTINS;

EID: 33750951421     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.09.001     Document Type: Article

References (35)

1. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., et al. Mice deficient for corticotropin-realising hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24 (2000) 410-414
2. Behan D.P., Grigoriadis D.E., Lovenberg T., Chalmers D., Heinrichs S., Liaw C., et al. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders. Mol Psychiatry 4 (1996) 265-277
3. Chalmers D.T., Lovenberg T.W., and De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15 (1995) 6340-6350
4. Ciccocioppo R., Martin-Fardon R., Weiss F., and Massi M. Nociceptin/Orphanin FQ inhibits stress- and CRF-induced anorexia in rats. Neuroreport 12 (2001) 1145-1149
5. Ciccocioppo R., Biondini M., Antonelli L., Wichmann J., Jenck F., and Massi M. Reversal of stress- and CRF-induced anorexia in rats by the synthetic Nociceptin/Orphanin FQ receptor agonist, Ro 64-6198. Psychopharmacology 161 (2002) 113-119
6. Ciccocioppo R., Fedeli A., Economidou D., Policani F., Weiss F., and Massi M. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by Nociceptin/Orphanin FQ. J Neurosci 23 (2003) 9445-9451
7. Contarino A., Dellu F., Koob G.F., Smith G.W., Lee K.F., Vale W.W., et al. Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice. Endocrinology 141 (2000) 2698-2702
8. Heinrichs S.C., Lapsansky J., Lovenberg T.W., De Souza E.B., and Chalmers D.T. Corticotropin-realising factor CRF1 but not CRF2, receptor mediate anxiogenic-like behavior. Regul Pept 71 (1997) 15-21
9. Higgins G.A., Grottick A.J., Ballard T.M., Richards J.G., Messer J., Takeshima H., et al. Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function. Neuropharmacology 41 (2001) 97-107
10. Hsu S.Y., and Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7 (2001) 605-611
11. Ikeda K., Watanabe M., Ichikawa T., Kobayashi T., Yano R., and Kumanishi T. Distribution of prepro-Nociceptin/Orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J Comp Neurol 399 (1998) 139-151
12. Inoue K., Valdez G.R., Reyes T.M., Reinhardt L.E., Tabarin A., Rivier J., et al. Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the Rat. J Pharmacol Exp Ther 305 (2003) 385-393
13. Jahn O., Tezval H., van Werven L., Eckart K., and Spiess J. Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity. Neuropharmacology 47 (2004) 233-242
14. Jenck F., Wichmann J., Dautzenberg F.M., Moreau J.L., Ouagazzal A.M., Martin J.R., et al. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc Natl Acad Sci USA 25 (2000) 4938-4943
15. Levine A.S., Rogers B., Kneip J., Grace M., and Morley J.E. Effect of centrally administered corticotropin releasing factor (CRF) on multiple feeding paradigms. Neuropharmacology 22 3 (1983) 337-339
16. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98 (2001) 7570-7575
17. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., and Donaldson C. Identification of urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours. J Neuroendocrinol 15 5 (2004) 411-422
18. Muller M.B., Zimmermann S., Sillaber I., Hagemeyer T.P., Deussing J.M., Timpl P., et al. Limbic corticotropin realising hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci 6 (2003) 1100-1107
19. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., and Watson Jr. S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol 406 (1999) 503-547
20. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Akil H., et al. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol 412 (1999) 563-605
21. Ohata H., and Shibasaki T. Effects of urocortin 2 and 3 on motor activity and food intake in rats. Peptides 25 (2004) 1703-1709
22. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 2nd ed. (1986), Academic Press, North Ryde, NSW, Australia
23. Pelleymounter M.A., Joppa M., Ling N., and Foster A.C. Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin III. Peptides 25 (2004) 659-666
24. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98 (2001) 2843-2848
25. Risbrough V.B., Hauger R.L., Pelleymounter M.A., and Geyer M.A. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology (Berl) 170 2 (2003) 178-187
26. Risbrough V.B., Hauger R.L., Roberts A.L., Vale W.W., and Geyer M.A. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J Neurosci 24 29 (2004) 6545-6552
27. Rominger A., Rominger C.M., Fitzgerald L.W., Grzanna R., Largent B.L., and Zaczek R. Characterization of 125I sauvagine binding to CRH2 receptors: membrane homogenate and autoradiographic studies. J Pharmacol Exp Ther 286 (1998) 459-548
28. Sanchez M.M., Young L.J., Plotsky P.M., and Insel T.R. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol 408 (1999) 365-377
29. Sekino A., Ohata H., Mano-Otagiri A., Arai K., and Shibasaki T. Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats. Psychopharmacology 176 (2004) 30-38
30. Sim L.J., and Childers S.R. Anatomical distribution of mu, delta, and kappa opioid- and Nociceptin/Orphanin FQ-stimulated [35S]guanylyl-5′-O-(gamma-thio)-triphosphate binding in guinea pig brain. J Comp Neurol 386 (1997) 562-572
31. Sinnayah P., Blair-West J.R., McBurnie M.I., McKinley M.J., Oldfield B., et al. The effect of urocortin on ingestive behaviours and brain Fos immunoreactivity in mice. Eur J Neurosci 18 2 (2003) 373-382
32. Smagin G.N., Howell L.A., Ryan D.H., De Souza E.B., and Harris R.B. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia. Neuroreport 9 7 (1998) 1601-1606
33. Spina M., Merlo-Pich E., Chan R.K., Basso A.M., Rivier J., Vale W., et al. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273 5281 (1996) 1561-1564
34. Timpl P., Spanagal R., Sillabar I., Kresse A., Reul J.M., Stalla G.K., et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-realins hormone receptor 1. Nat Genet 19 (1998) 162-166
35. Zorrilla E.P., Reinhardt L.E., Valdez G.R., Inoue K., Rivier J.E., Vale W.W., et al. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist differentially alter feeding and motor activity. J Pharmacol Exp Ther 310 3 (2004) 1027-1034